Page last updated: 2024-12-08

bandrowski's base

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bandrowski's base: reported cause of anaphylactic reaction; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Bandrowski's base : A quinone imine having amino substituents in the 2- and 5-positions and 4-aminophenyl substituents on both of the imine nitrogens. It is a trimer formed from 1,4-phenylenediamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID159881
CHEBI ID53109
SCHEMBL ID1881206
SCHEMBL ID6125203
MeSH IDM0146783

Synonyms (31)

Synonym
1,4-cyclohexadiene-1,4-diamine, 3,6-bis((p-aminophenyl)imino)-
brn 2395527
1,4-benzenediamine, n,n''-(2,5-diamino-2,5-cyclohexadiene-1,4-diylidene)bis-
bandrowski's base
n1,n1'-(2,5-diaminocyclohexa-2,5-diene-1,4-diylidene)dibenzene-1,4-diamine
20048-27-5
3,6-bis[(p-aminophenyl)imino ]cyclohexa-1,4-diene-1,4-diamine
bb
3,6-bis((p-aminophenyl)imino)-1,4-cyclohexadiene-1,4-diamine
n(1),n(1)'-(2,5-diaminocyclohexa-2,5-diene-1,4-diylidene)dibenzene-1,4-diamine
CHEBI:53109 ,
3,6-bis[(4-aminophenyl)imino]cyclohexa-1,4-diene-1,4-diamine
SCHEMBL1881206
n',n'-bis(4-aminophenyl)-2,5-diamino-1,4-quinonediimine
3-14-00-00363 (beilstein handbook reference)
63zre89t3q ,
unii-63zre89t3q
EPITOPE ID:112870
DTXSID9044031
SCHEMBL6125203
n,n-(2,5-diamino-2,5-cyclohexadiene-1,4-diylidene)bis-1,4-benzenediamine
1,4-benzenediamine, n,n-(2,5-diamino-2,5-cyclohexadiene-1,4-diylidene)bis-
J-012976
bandrowskis base
(n1,n1'e,n1,n1'z)-n1,n1'-(2,5-diaminocyclohexa-2,5-diene-1,4-diylidene)dibenzene-1,4-diamine
2,5-diamino-n,n'-di-(4-aminophenyl)-2,5-cyclohexadiene-1,4-diimine
Q27123965
n,n'-(2,5-diamino-2,5-cyclohexadiene-1,4-diylidene)bis-1,4-benzenediamine
Q27263671
4-diamine,3,6-bis((p-aminophenyl)imino)-4-cyclohexadiene-1
3,6-bis((4-aminophenyl)imino)cyclohexa-1,4-diene-1,4-diamine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.53)18.7374
1990's3 (15.79)18.2507
2000's11 (57.89)29.6817
2010's3 (15.79)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.02 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.26%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]